Novo CEO pressed by Senate to chop rates of being overweight, diabetes medications CEO Lars Fruergaard Jørgensen told lawmakers the company would take into account new talks with insurers about the checklist price ranges of Wegovy and copyright if they pledge to help keep the medicines on their own formularies. https://griffinkgday.blogozz.com/30066415/an-unbiased-view-of-healthcare-news